Case report from the NOUS-209-01 trial describes a patient with mismatch repair-deficient colorectal cancer who achieved complete pathologic response and significant colonic polyp regression following treatment with Nous-209 plus pembrolizumab. (Journal of Immunotherapy and Precision Oncology)
Immunotherapy Combination Achieves Complete Response and Polyp Regression in dMMR Colorectal Cancer
The CRC Digest